ⓘ Landogrozumab

                                     

ⓘ Landogrozumab

Landogrozumab is a humanized monoclonal antibody and experimental pharmaceutical drug designed for the treatment of muscle wasting disorders.

This drug developed by Eli Lilly & Co.